Share on StockTwits

XOMA Corp (NASDAQ:XOMA) was upgraded by equities researchers at MLV & Co
from a “hold” rating to a “buy” rating in a research report issued on Tuesday, TheFlyOnTheWall.com reports. The firm currently has a $7.00 price target on the stock. MLV & Co
‘s target price points to a potential upside of 52.51% from the company’s current price. The analysts noted that the move was a valuation call.

Other equities research analysts have also recently issued reports about the stock. Analysts at TheStreet downgraded shares of XOMA Corp from a “hold” rating to a “sell” rating in a research note on Friday, March 7th. Separately, analysts at Ladenburg Thalmann raised their price target on shares of XOMA Corp from $6.50 to $10.00 in a research note on Wednesday, March 5th. They now have a “buy” rating on the stock. Finally, analysts at Canaccord Genuity raised their price target on shares of XOMA Corp from $8.00 to $10.00 in a research note on Wednesday, March 5th. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $9.00.

In other XOMA Corp news, CEO John Varian sold 10,000 shares of XOMA Corp stock in a transaction that occurred on Tuesday, April 15th. The shares were sold at an average price of $4.06, for a total transaction of $40,600.00. Following the completion of the sale, the chief executive officer now directly owns 285,613 shares in the company, valued at approximately $1,159,589. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

XOMA Corp (NASDAQ:XOMA) traded up 20.16% during mid-day trading on Tuesday, hitting $4.59. 5,754,284 shares of the company’s stock traded hands. XOMA Corp has a 52-week low of $3.02 and a 52-week high of $9.57. The stock’s 50-day moving average is $5.00 and its 200-day moving average is $5.95. The company’s market cap is $489.2 million.

XOMA Corp (NASDAQ:XOMA) last announced its earnings results on Tuesday, March 4th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.36. The company had revenue of $8.45 million for the quarter, compared to the consensus estimate of $7.92 million. XOMA Corp’s revenue was up 69.6% compared to the same quarter last year. Analysts expect that XOMA Corp will post $-0.69 EPS for the current fiscal year.

XOMA Corporation (NASDAQ:XOMA) is engaged in the discovery and development of antibody-based therapeutics.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.